National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1699309

Government Disclaimer on use of this data



Case Details

VAERS ID: 1699309 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Metastases to lung, Pulmonary imaging procedure
SMQs:, Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-07-27
   Days after onset: 117
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Lung lobectomy; Lung neoplasm NOS
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: Pulmonary imaging procedure; Result Unstructured Data: Test Result:clean lung image; Test Date: 202104; Test Name: Pulmonary imaging procedure; Result Unstructured Data: Test Result:metastases in the right lobe of the lung; Comments: metastases in the right lobe of the lung, about 1/3 of the respiratory surface remained
CDC Split Type: HUPFIZER INC202101158299

Write-up: Metastasis in lung/dyspnoea; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Agency-WEB, regulatory authority number HU-OGYI-719221. This spontaneous, serious case was reported by a patient''s relative on 23/08/2021, concerning the occurrence of metastasis in lung after the administration of Comirnaty concentrate for dispersion for injection (30 micrograms of COVID-19 mRNA Vaccine, MAH: BioNTech Manufacturing GmbH/ Pfizer). On 01/04/2021 (at the vaccination age of 60 years old), the 60-year-old female patient received the first dose of Comirnaty (COVID-19 mRNA Vaccine (nucleoside modified)/ Tozinameran) concentrate for dispersion for injection (strength: 1 dose (0.3 mL) contains 30 micrograms of COVID-19 mRNA Vaccine, intramuscularly, batch number: unknown) for COVID-19 immunisation. On 01/04/2021, the patient experienced dyspnoea, and in the end of 04/2021, metastases were found in the right lobe of the lung by unspecified pulmonary imaging procedure, approximately 1/3 of the lung surface remained clean. The patient died on 27/07/2021 among the symptoms of respiratory arrest. There is no information about whether autopsy was done. Medical history included lung lobectomy in 03/2021 due to a tumor. Clean image of the lung was seen in 01/2021.Concomitant medications were unspecified antihipertensive and antidiabetic medication. No further information is expected. Sender''s comments: Metastases occurred in lung within a month, and the patient died 3 months after Comirnaty vaccination. There is no information about whether autopsy was done. The causal relationship between the reported event and Comirnaty is unassessable. The case is serious due to fatal outcome. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Metastasis in lung/dyspnoea; Respiratory arrest


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1699309


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166